No abstract available
MeSH terms
-
Adalimumab
-
Adolescent
-
Adult
-
Anti-Inflammatory Agents / adverse effects*
-
Anti-Inflammatory Agents / therapeutic use
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Drug Therapy, Combination
-
Female
-
Humans
-
Inflammatory Bowel Diseases / complications
-
Inflammatory Bowel Diseases / drug therapy*
-
Infliximab
-
Liver Neoplasms / chemically induced*
-
Lymphoma, T-Cell / chemically induced*
-
Male
-
Splenic Neoplasms / chemically induced*
-
Young Adult
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Infliximab
-
Adalimumab